An immediate hazard is a situation in which delay would jeopardize the protection of a trial participant and therefore an immediate deviation from the protocol may be necessary. ICH E6(R3) permits the investigator to make such a deviation solely to eliminate the hazard. The sponsor must be informed without delay; subsequently, the cause, follow-up measures, and any need for amendment are reviewed.
Exception to Protocol Adherence
The approved protocol is fundamentally binding. Changes or deviations should not be initiated without prior documented approval from the responsible ethics committee or competent body. The immediate hazard is the narrowly defined exception: the investigator may deviate only to the extent necessary to eliminate an acute hazard to participants. It is not a general authorization to resolve organizational difficulties, recruitment problems, or subsequent preferences through deviating procedures.
The situation and the implemented change must be documented promptly. The investigator informs the sponsor without delay and reports the hazard, the change, and, where applicable, the subsequently proposed protocol amendment to the ethics committee and authorities in accordance with applicable requirements. The documentation must demonstrate why the hazard was immediate, why the chosen measure was necessary, and which persons or data may be affected.
Sponsor Obligations Following Acute Measures
The sponsor addresses the notification within its safety and quality management system. The sponsor clarifies the cause, evaluates possible further risks, and initiates appropriate corrective actions. This may include informing other sites, restricting the use of an investigational product, or requesting an amendment to the protocol. If a comparable hazard recurs, it must be assessed whether the protective measures, training, or risk assessment of the entire trial were inadequate.
Distinction from Protocol Deviation and Urgent Safety Measure
A protocol deviation initially describes only the deviation from the protocol. The deviation to eliminate an immediate hazard is special because it may be permissible despite the absence of prior approval. It must still be documented and evaluated; the exception concerns the timing of action, not the waiver of accountability or follow-up.
The urgent safety measure is the concrete protective action in response to an unexpected safety situation and may be implemented by the sponsor or investigator. The immediate hazard, by contrast, is the triggering condition that specifically justifies the investigator’s immediate deviation. Such a deviation may be part of an urgent safety measure, but both terms address different questions: hazard situation on the one hand, protective measure on the other.
An immediate hazard is not determined by an abstract checklist, but by the specific clinical situation and the urgency of protection. Nevertheless, predefined reporting pathways help ensure that the required decision is documented and communicated to the sponsor without avoidable delay. The site should record which part of the protocol was affected, which alternative was chosen, and whether the intervention, follow-up, or information to other parties had to be adjusted. The sponsor should subsequently assess whether comparable situations are conceivable at other sites. A single acute deviation may indicate that inclusion and exclusion criteria, dosing rules, emergency plans, or training need to be refined. The primacy of participant protection always remains independent of recruitment targets, data completeness, or organizational interests.
Even after the acute hazard has been resolved, the case should be evaluated promptly. The evaluation demonstrates whether the exception remained narrowly defined and whether preventive changes are required for similar situations. This connects immediate clinical protection with sustainable improvement in trial conduct.
The decision must not be delayed by lack of communication. Clear points of contact and a brief, factual initial notification to the sponsor ensure subsequent evaluation.
The related term well-being of the trial participant describes the overarching protective standard. The immediate hazard, by contrast, designates the acute situation that justifies an immediate, narrowly defined deviation from the protocol; it is not synonymous with every protocol deviation.
Relevance for clinical trials
At the trial site, clinical decisions and trial processes must be connected in such a way that acute protective measures are not delayed by unclear responsibilities. At the same time, reliable pathways are needed for immediate communication to the sponsor, medical evaluation, and regulatory follow-up. Inspections frequently examine whether exceptional decisions were demonstrably limited and whether systematic lessons were drawn from them.
Full-service CROs such as Mediconomics provide support with reporting pathways, training for trial sites, medical evaluation, and documentation of deviations. They coordinate root cause analysis, communication with ethics committees and authorities, and, where applicable, preparation of a protocol amendment.
Frequently Asked Questions (FAQ)
May the investigator act immediately in the event of an immediate hazard?
Yes, to the extent that the deviation is necessary to eliminate the immediate hazard to participants.
Is every adverse reaction an immediate hazard?
No. A situation is required that makes immediate deviation necessary to protect the participants concerned.
Must the deviation be approved subsequently?
The acute action is not approved in advance. However, the hazard, the change, and any subsequent protocol amendment must be reported and evaluated in accordance with applicable requirements.
Regulatory References
- ICH E6(R3), Sections 1.4.7, 2.5.4, 2.5.5, and 3.13.3 — describes the procedure for immediate hazards.
- Regulation (EU) No 536/2014, Article 54 — governs urgent safety measures.
- European Commission Q on Regulation (EU) No 536/2014, Chapters 10.4 to 10.7 — distinguishes between interruption, resumption, and safety measure.
